Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation.

Bo Zhao, Xin Hu, Yuning Zhou, Yueru Shi, Rui Qian, Youzhong Wan

Biochemical and biophysical research communications 2021 Mar 26

filter terms:

SF3B1, an essential component of the U2 snRNP, is frequently mutated in cancers. Cancer-associated SF3B1 mutation causes aberrant RNA splicing, mostly at 3' splice sites (3'ss). RNA splicing of DVL2, a regulator of Notch signaling, is affected by SF3B1 mutation. Here, we report that the mutated SF3B1 use an alternative branchpoint sequence (BPS) for the aberrant splicing of DVL2, which has a higher affinity to U2 snRNA than the BPS for the canonical splicing of DVL2. Swapping the position of the alternative BPS with the position of the canonical BPS decreased the aberrant splicing of DVL2, suggesting that the mutated SF3B1 prefers to use BPS with high affinity to U2 snRNA for splicing. Additionally, swapping the positions of two BPSs associated with the canonical splicing of DVL2 demonstrated that both the affinity to the U2 snRNA and the distance to the 3'ss are important to the selection of BPS. Importantly, the aberrant splicing of DVL2 does not require the canonical 3'ss and the canonical polypyrimidine tract, which reveals a novel type of aberrant splicing induced by SF3B1 mutation. These findings provide a more comprehensive understanding of the mechanisms underlying aberrant splicing induced by SF3B1 mutation in cancer. Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Citation

Bo Zhao, Xin Hu, Yuning Zhou, Yueru Shi, Rui Qian, Youzhong Wan. Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation. Biochemical and biophysical research communications. 2021 Mar 26;546:21-28